In this article, we sit down for a conversation with Brandon Barksdale, CEO of Dalwhinnie Enterprises LLC, to hear about his journey through the cannabis industry, entrepreneurship, social equity, their unique locations and more.
According to two press releases published today, Curaleaf Holdings, Inc. has acquired Arizona-based Bloom Dispensaries for roughly $211 million, taking the company’s four retail locations and their two cultivation/processing locations in Arizona. Additionally, Curaleaf announced two new retail locations in Tampa Bay and Largo, Florida.
This column provides readers with a taste of Cannin’s insights they offer to their members, including investment tips, trends, predictions and more. In this piece, we take a look at Tilray’s position following Q2 reporting.
In this piece, the authors examine the “The Treasure State’s” cannabis industry, the new adult use program and the taxes that impact it.
When it comes to mitigating risk in this business, the stakes are sky high. Cannabis companies that have not incorporated risk management into their business/operational plans will need to in 2022. Here are five types of insurance that you should consider.
The cannabis industry is set for another year of huge growth in 2022, but the path ahead is not without its bumps. Growers, processors and retailers will need to leverage risk management to minimize threats to their profitability and stability.
What do social consumption lounges look like in practice? What are the rules and regulations that social consumption lounges must adhere to? How and where are social consumption lounges currently legal in the United States? Here’s what you need to know.
When creating your cannabis brand’s visual identity, choosing the right design style is vital. The development process includes creating a brand ethos, understanding your customer, defining a brand personality, budget and time considerations and choosing a designer. While illustration can certainly take your cannabis brand’s visual identity to the next level, there are a number of factors to consider when developing your strategy.
ASTM International released a technical paper on delta-8-THC, reporting on the risks, regulatory landscape and more. On the same day, the U.S. Pharmacopeia (USP) launched an expert panel, drafting commentary and providing recommendations to protect public health.
Your cannabis products deserve to stand out and shine in this booming market. But your product won’t even make it to the market if you are not following label requirements. Following these Do’s and Don’ts will help you label your products appropriately.
